Advertisement

Ads Placeholder
Loading...

ZIOPHARM Oncology, Inc.

ZIOP•NASDAQ
Healthcare
Biotechnology
$0.87
$-0.01(-0.88%)
U.S. Market opens in 3h 49m

ZIOPHARM Oncology, Inc. (ZIOP) Stock Overview

Explore ZIOPHARM Oncology, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap208.1M
P/E Ratio-0.40
EPS (TTM)$-0.42
ROE-1.73%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$2.52

ZIOP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ZIOPHARM Oncology, Inc. (ZIOP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.40 and a market capitalization of 208.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-72.95%
5-Year Change
-78.03%
All-Time (Max) Change
-94.59%

Contact Information

https://ziopharm.com
16172591970
One First Avenue Parris Building 34, Navy Yard Plaza, Boston, MA, 02129

Company Facts

1,030 Employees
IPO DateAug 20, 2004
CountryUS

Frequently Asked Questions